The Department of Pharmacology and Cancer Biology hosts two seminar programs to share the work being done by our students, postdocs, and faculty and to provide opportunities to learn from others in the field, both within and outside Duke.
PCB Seminar Series, Regulatory Networks in Health and Disease is our weekly departmental seminar series held each Wednesday at 12:00 noon. This seminar series features (mostly) invited speakers from outside the Duke community. The 2025-2026 series will be announced in the summer.
Works in Progress (WIP) is our signature departmental event which takes place at 12:00 noon on Fridays. The aim of this event is to increase cohesiveness and collaboration throughout our department, while also providing trainees with a valuable forum for feedback. The 2025-2026 series will be announced in the summer.
RNHD | Stockwell: Ferroptosis and metabolism—mechanisms and therapeutic implications
Brent R. Stockwell, PhD, William R. Kenan, Jr. Professor of Biological Sciences; Chair, Department of Biological Sciences, and Professor of Chemistry, Columbia University; and Professor of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
to
The 2026 Robert J. Lefkowitz, MD, Distinguished Lecture "Emerging indications, molecules and mechanisms for GLP-1 medicines"
Daniel Drucker, MD Professor, Department of Medicine, Temerty Faculty of Medicine Senior Scientist, Lunenfeld-Tanenbaum Research Institute Mt. Sinai Hospital, University of Toronto
to
PCB Works in Progress
Derek Zachman, MD, PhD (Hirschey Lab) & Paige Burrell, PhD (Kastan Lab)
to
RNHD | Houlahan: Germline-mediated immunoediting in cancer
Kathleen Houlahan, PhD, Assistant Professor, Department of Biochemistry & Biomedical Sciences, Principal Investigator, Centre for Discovery in Cancer Research, McMaster University
to
PCB Works in Progress
Yiran Guo, PhD (Greg Wang Lab) & Meagan Luck (Darnell Lab)
to
RNHD | Shalek: Identifying & Counteracting The Impact Of Environment Stress On Tissue Dysfunction
Alex K. Shalek, PhD, Director, Institute for Medical Engineering & Science and Health Innovation Hub, MIT; J. W. Kieckhefer Professor, Institute for Medical Engineering & Science, Department of Chemistry, and Koch Institute, MIT; Ragon Institute | Broad Institute | HMS | MGB
to